Literature DB >> 23954886

Trends in recognition and treatment of dementia in france analysis of the 2004 to 2010 database of the national health insurance plan.

Marion Bertrand1, Christophe Tzourio, Annick Alpérovitch.   

Abstract

Dementia is considered as underdiagnosed. We examined whether the proportion of persons aged 65 years and older who had been diagnosed as demented has changed over a 7-year period. The study population was constituted by a cohort of about 70,000 persons who were representative of the French elderly covered by the national health care insurance plan. Data about all health care consumptions were extracted from the national insurance database. Patients using an antidementia drug, having a special dementia-related coverage status, or both were identified. Annual age-standardized and sex-standardized proportions of recognized dementia cases were estimated. Between 2004 and 2010, the overall standardized proportion of persons recognized as having dementia increased slightly but significantly (P<0.004) from 3.68% to 4.20%. The proportion of persons recognized as demented increased strongly with age. In 2010, it increased from 1.44% at age 70-74 to 10% at age more than 90 in men and from 1.30% to 17.0% in women. The proportion of cholinesterase inhibitor users decreased after the age of 85 years, whereas memantine use continued to increase. Our study suggested that, in 2010, >75% of the demented persons had been recognized and received pharmacological or/and nonpharmacological therapies for dementia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23954886     DOI: 10.1097/WAD.0b013e3182695a3b

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  5 in total

1.  Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings.

Authors:  Adeline Gallini; Sandrine Andrieu; Julie M Donohue; Naïma Oumouhou; Maryse Lapeyre-Mestre; Virginie Gardette
Journal:  Eur Neuropsychopharmacol       Date:  2013-09-17       Impact factor: 4.600

2.  Older age at retirement is associated with decreased risk of dementia.

Authors:  Carole Dufouil; Edwige Pereira; Geneviève Chêne; M Maria Glymour; Annick Alpérovitch; Elodie Saubusse; Mathilde Risse-Fleury; Brigitte Heuls; Jean-Claude Salord; Marie-Anne Brieu; Françoise Forette
Journal:  Eur J Epidemiol       Date:  2014-05-04       Impact factor: 8.082

Review 3.  The changing prevalence and incidence of dementia over time - current evidence.

Authors:  Yu-Tzu Wu; Alexa S Beiser; Monique M B Breteler; Laura Fratiglioni; Catherine Helmer; Hugh C Hendrie; Hiroyuki Honda; M Arfan Ikram; Kenneth M Langa; Antonio Lobo; Fiona E Matthews; Tomoyuki Ohara; Karine Pérès; Chengxuan Qiu; Sudha Seshadri; Britt-Marie Sjölund; Ingmar Skoog; Carol Brayne
Journal:  Nat Rev Neurol       Date:  2017-05-12       Impact factor: 42.937

4.  Prescription Patterns of Medications for Alzheimer's Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study.

Authors:  Kimiko Kadohara; Izumi Sato; Yuko Doi; Masaru Arai; Yosuke Fujii; Toshiyuki Matsunaga; Koji Kawakami
Journal:  Neurol Ther       Date:  2016-11-28

5.  Secular trends in the prevalence of dementia based on a community-based complete enumeration in Japan: the Nakayama Study.

Authors:  Hideaki Shimizu; Takaaki Mori; Taku Yoshida; Ayumi Tachibana; Tomoki Ozaki; Yuta Yoshino; Shinichiro Ochi; Naomi Sonobe; Teruhisa Matsumoto; Kenjiro Komori; Jun-Ichi Iga; Toshiharu Ninomiya; Shu-Ichi Ueno; Manabu Ikeda
Journal:  Psychogeriatrics       Date:  2022-06-26       Impact factor: 2.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.